Last CNY16.76 CNY
Change Today -0.29 / -1.70%
Volume 5.7M
As of 2:05 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

jiangsu lianhuan pharmaceu-a (600513) Snapshot

Open
CNY17.20
Previous Close
CNY17.05
Day High
CNY17.35
Day Low
CNY16.61
52 Week High
10/16/14 - CNY21.20
52 Week Low
04/28/14 - CNY10.32
Market Cap
2.6B
Average Volume 10 Days
6.4M
EPS TTM
CNY0.28
Shares Outstanding
156.7M
EX-Date
06/19/14
P/E TM
59.2x
Dividend
CNY0.09
Dividend Yield
0.45%
Current Stock Chart for JIANGSU LIANHUAN PHARMACEU-A (600513)

Related News

No related news articles were found.

jiangsu lianhuan pharmaceu-a (600513) Related Businessweek News

No Related Businessweek News Found

jiangsu lianhuan pharmaceu-a (600513) Details

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is engaged in the research, development, manufacture, and sale of pharmaceutical products in China. The company also offers chemical raw materials and medicine preparations. Its primary products include steroid hormone, antibiotic, antihistamine, cardiovascular, anti-allergic, and urological surgery drugs, such as felodipine, ebastine, terfenadine, cetirizine and sertraline hydrochloride, lithium carbonate, doxycycline hydrochloride, balofloxacin, and metformin gliclazide tablets; danazol, Lumbrokinase enteric-coated, and pseudoephedrine capsules; and simvastatin and epristeride piece, as well as injections of sodium sulfate prasterone. The company is based in Yangzhou, China.

jiangsu lianhuan pharmaceu-a (600513) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu lianhuan pharmaceu-a (600513) Key Developments

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Three Quarters of 2014

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. announced earnings results for the first three quarters of 2014. For the period, the company reported basic earnings per share of CNY 0.22, hiking 22.22% from CNY 0.18 a year ago. Weighted average return on net assets was 8.16%. Net profit attributable to shareholders was CNY 34 million, rising 21.13% from CNY 28 million a year earlier.

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. to Report Q3, 2014 Results on Oct 29, 2014

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. announced that they will report Q3, 2014 results on Oct 29, 2014

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. Proposes Amending Articles of Association

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. proposed amending articles of association to the EGM to be held on September 10, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600513:CH CNY16.76 CNY -0.29

600513 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600513.
View Industry Companies
 

Industry Analysis

600513

Industry Average

Valuation 600513 Industry Range
Price/Earnings 60.2x
Price/Sales 3.8x
Price/Book 6.0x
Price/Cash Flow 59.5x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGSU LIANHUAN PHARMACEU-A, please visit www.lhpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.